Literature DB >> 9681083

Hereditary persistence of alpha-fetoprotein. Case report and review of the literature.

H Schefer1, S Mattmann, R A Joss.   

Abstract

Persistently elevated alpha-fetoprotein (AFP) levels of 24 to 30 micrograms/ml (normal < 10 micrograms/ml) were found in a 38-year-old healthy man. Subsequently, AFP was found to be elevated in another five out of 13 family members within three generations. The pedigree is consistent with an autosomal dominant inheritance pattern. No discernible disease and no functional abnormality appears to be associated with this clinically benign disorder which has been recorded in the literature on four occasions to date. The reported AFP levels in these other cases ranged from 18 to 198 micrograms/ml. Physiologically, AFP is mainly produced in the liver and the yolk sac of human fetuses more than four weeks old, with peak values of up to 4 mg/ml at 12 to 16 weeks of gestation. After birth, AFP levels usually fall, within eight to 12 months, to a very low concentration of < 10 micrograms/ml and persist at low levels throughout life. However, AFP levels can rise above normal in both children and adults in distinct conditions and diseases which will be discussed. Hereditary persistence of alpha-fetoprotein (HPAFP) should be considered in both children and adults with unexplained and persistent elevation of AFP e.g., those screened for hepatocellular carcinoma or diagnosed for germ cell tumor. It should also be recognized in AFP screening for neural tube defects or Down's syndrome during pregnancy. Hereditary persistence of AFP can be easily confirmed by analyzing AFP levels in family members.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681083     DOI: 10.1023/a:1008243311122

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  8 in total

Review 1.  Late relapse of testis cancer.

Authors:  Yaron Ehrlich; Eli Rosenbaum; Jack Baniel
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

2.  Current imaging strategies of primary and secondary neoplasms of the liver.

Authors:  Linda Fielding
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

Review 3.  Testicular cancer from diagnosis to epigenetic factors.

Authors:  Mariarosaria Boccellino; Daniela Vanacore; Silvia Zappavigna; Carla Cavaliere; Sabrina Rossetti; Carmine D'Aniello; Paolo Chieffi; Evzen Amler; Carlo Buonerba; Giuseppe Di Lorenzo; Rossella Di Franco; Alessandro Izzo; Raffaele Piscitelli; Gelsomina Iovane; Paolo Muto; Gerardo Botti; Sisto Perdonà; Michele Caraglia; Gaetano Facchini
Journal:  Oncotarget       Date:  2017-09-18

4.  Hereditary Persistence of Alpha-Fetoprotein Is Associated with the -119G>A Polymorphism in AFP Gene.

Authors:  Neha Deshpande; Radhika Chavan; Govardhan Bale; Urmila Steffie Avanthi; Mohsin Aslam; Mohan Ramchandani; D Nageshwar Reddy; V V Ravikanth
Journal:  ACG Case Rep J       Date:  2017-03-01

5.  Association of Common Variants in HNF1A Gene with Serum AFP Level in Healthy Chinese Individuals and HCC Patients.

Authors:  Xue-Jun Li; Dong-Hua Shao; Mei-Lin He; Guo-Wei Liang
Journal:  Dis Markers       Date:  2019-11-07       Impact factor: 3.434

6.  Idiopathic portal hypertension in an "inactive" HBV carrier: a case report.

Authors:  Themistoklis G Vassiliadis; Anthia Gatopoulou; Kaliopi Patsiaoura; Olga Giouleme; Konstantinos Soufleris; Alexandros Boubonaris; Panagiotis Katsinelos; Nikolaos Eugenidis
Journal:  Cases J       Date:  2008-10-08

Review 7.  Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance.

Authors:  Jaclyn C Milose; Christopher P Filson; Alon Z Weizer; Khaled S Hafez; Jeffrey S Montgomery
Journal:  Open Access J Urol       Date:  2011-12-30

Review 8.  Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma.

Authors:  Hira Hanif; Mukarram Jamat Ali; Ammu T Susheela; Iman Waheed Khan; Maria Alejandra Luna-Cuadros; Muzammil Muhammad Khan; Daryl Tan-Yeung Lau
Journal:  World J Gastroenterol       Date:  2022-01-14       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.